Scilex Holding Co
Develops and commercializes non-opioid products for acute and chronic pain management.
SCLX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US80880W2052 (+3 more)
- LEI:
- Country:
- United States of America
- Address:
- 960 SAN ANTONIO ROAD, 94303 PALO ALTO
- Website:
- https://www.scilexholding.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Scilex Holding Company is an innovative pharmaceutical company focused on acquiring, developing, and commercializing non-opioid products for the management of acute and chronic pain. The company's portfolio is designed to provide effective alternatives to traditional opioid medications, aiming to improve patient quality of life. Scilex utilizes proprietary technologies, including advanced adhesion and drug delivery systems like transdermal patches, precision-dosing anti-inflammatory oral solutions, and liquid ready-to-use analgesics for conditions such as migraines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Scilex Holding Co filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Scilex Holding Co
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Scilex Holding Co via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
